Literature DB >> 218538

Stability and immunogenicity of empty particles of foot-and-mouth disease virus.

M M Rweyemamu, G Terry, T W Pay.   

Abstract

Three strains of foot-and-mouth disease virus were shown to contain significant amounts of naturally occurring 75S, empty particles as well as the infectious, 140S full particles. One of these strains--A Pando (1970)--was studied in detail. The empty particles from this virus strain were shown to have an observed sedimentation coefficient of 67S in 0.04 M phosphate buffer; they were labile in SDS, non-infectious and probably RNA-free and, on heating, they broke down to 12S subunits as did the 140S particles. The empty particles differed from the full particles in their polypeptide composition since they contained VP0, but there was no evidence for a diminished content of VP4. The 75S particles were shown to be present in significant amounts and to be stable to AEI inactivation. At 4 degrees C they were stable for at least two years. In guinea pigs they were as immunogenic as the 140S particles. The antisera raised against the 75S particles had the same serological specificity in neutralization tests as sera prepared against the 140S particle. It was concluded that the 75S particles from the A Pando (1970) strain of FMD virus may provide as important a contribution as 140S particles to the immunogenicity of inactivated vaccines prepared from this virus strain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218538     DOI: 10.1007/bf01317896

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  IN VITRO MEASUREMENT OF THE POTENCY OF INACTIVATED FOOT-AND-MOUTH DISEASE VIRUS VACCINES.

Authors:  F BROWN; J F NEWMAN
Journal:  J Hyg (Lond)       Date:  1963-09

2.  PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  F BROWN; B CARTWRIGHT
Journal:  Nature       Date:  1963-09-21       Impact factor: 49.962

3.  A 65 S PARTICLE CONTAINING VIRAL PROTEIN IN CELLS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  D N PLANTEROSE; J K RYAN
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

4.  [Various physical and chemical properties of the 73s unit of the foot-and-mouth disease virus].

Authors:  H T Liebermann; J Meissner; P Schulze; G Thalmann
Journal:  Arch Exp Veterinarmed       Date:  1976

5.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

Review 6.  Antibody response to viral antigens.

Authors:  K M Cowan
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

7.  In vitro method for safety testing of foot-and-mouth disease vaccines.

Authors:  E C Anderson; P B Capstick; G N Mowat; F B Leech
Journal:  J Hyg (Lond)       Date:  1970-06

8.  Evidence for an internal antigen in foot-and-mouth disease virus.

Authors:  D J Rowlands; B Cartwright; F Brown
Journal:  J Gen Virol       Date:  1969-06       Impact factor: 3.891

9.  A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.

Authors:  D J Rowlands; D V Sangar; F Brown
Journal:  J Gen Virol       Date:  1975-03       Impact factor: 3.891

10.  Some functional and morphological alterations occurring during and after the adaptation of BHK 21 clone 13 cells to suspension culture.

Authors:  P B Capstick; A J Garland; R C Masters; W G Chapman
Journal:  Exp Cell Res       Date:  1966-10       Impact factor: 3.905

View more
  25 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

5.  Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.

Authors:  V Ruiz; A C Mignaqui; M C Nuñez; E Reytor; J M Escribano; A Wigdorovitz
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

6.  Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.

Authors:  S Curry; E Fry; W Blakemore; R Abu-Ghazaleh; T Jackson; A King; S Lea; J Newman; D Stuart
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.

Authors:  T R Doel; W K Chong
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.

Authors:  S A Lewis; D O Morgan; M J Grubman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Guanidine and heat sensitivity of foot-and-mouth disease virus (FMDV) strains.

Authors:  P F Nettleton; M J Davies; M M Rweyemamu
Journal:  J Hyg (Lond)       Date:  1982-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.